Inaugural Neuroscience Conference set for November 15th & 16th

Translate to Spanish or other 102 languages!

Mega Doctor News

- Advertisement -

Edinburg, TX — The Continuing Medical Education Department at DHR Health is proud to present the Inaugural Neuroscience Conference.  The conference will convey best practices and provide practitioners with the knowledge to be able to recognize, diagnose and manage common neurological problems.  Speakers at the event will present and asses recent advancements and updates in Neuroscience.  The goal is to enhance the knowledge-base and core competence of all who attend. 

The Edinburg Conference Center at Renaissance will hold the event designed to educate physicians, advanced healthcare providers, nurses, EMS and those who have direct patient care.   Course registration will begin at 1:00 pm on Friday, November 15, 2019, and will conclude at 5:40 pm on Saturday, November 16, 2019.  This will be an informative event for practitioners who see patients with neurological disorders and who intend to provide a practical review with an emphasis in recent advances and current neuroscience guidelines. 

Attendees will hear from distinguished Neurology faculty speakers from John Hopkins University School of Medicine, Vanderbilt University Medical Center, Baylor College of Medicine, University of Illinois Department of Neurology and from DHR distinguished faculty of Neurology, Neurosurgery, Neurointerventional Radiology, Pediatric Neurology, Physical Medicine & Rehabilitation, and Palliative Medicine.  

- Advertisement -

Speakers will discuss the following topics: 

  • Diagnosing and managing common neurological problems
  • Evaluating and treating patients with various types of dementia, tremor and Parkinson’s disease
  • Evaluating and treating patients with Multiple sclerosis
  • Management of patients with strokes and implementing secondary prevention strategies
  • Identify and differentiate types of seizures and develop a management plan
  • Describe and Formulate an approach to diagnosis and management of peripheral neuropathies.

Inaugural Neuroscience Conference

Friday, November 15th– Saturday, November 16th, 2019 /  7:00 AM registration, 2-Day conference

Edinburg Conference Center at Renaissance

- Advertisement -

118 Paseo Del Prado, Edinburg, TX 78539

Breakfast & Lunch will be provided on Saturday

Register by phone at (956) 362-3242                                           

Earn up to 13.50 Credits:

12.75 CME PRA Category 1 Credits™

AMA PRA Category 1 Credits™

Nursing Contact Hours

Includes, 1.25 Ethic Hours

For more information about the Neuroscience Conference, please call the DHR Health Continuing Medical Education Department at (956) 362-3242 or email a.badillo@dhr-rgv.com.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS Takes Aim at Breast Cancer with New ‘Cinco de Mammo’ Campaign

To officially kick off this year’s initiative and commemorate Cinco de Mayo, STHS hosted a special luncheon on Tuesday, May 5, 2026, a gathering rooted in compassion, courage and unity. 

Texas Rural Health Gets $56M Lifeline for Prevention and Wellness Programs

Governor Greg Abbott announced the Texas Health and Human Services Commission (HHSC) will award $56 million in federal funding to rural hospitals advancing prevention, wellness, and nutrition programs in their communities.

Op Ed: Mental Health Can’t Wait: Break the Silence, Ignite Change 

May is Mental Health Awareness Month, a national observance that has been recognized since 1949, but its message has never been more urgent. In the United States, nearly 1 in 5 adults is living with a mental health condition, and more than 1 in 20 experience a serious mental illness that significantly interferes with daily life.

Study Projects Thousands of Missed Cancer Cases Under New Medicaid Rules

A research letter from experts at the University of Chicago Medicine, published in JAMA Oncology, warns that upcoming funding cuts and changes to federal Medicaid eligibility rules could lead to dramatic reductions in cancer screening for millions of Americans, ultimately worsening patient outcomes.
- Advertisement -